171 related articles for article (PubMed ID: 16499259)
1. Obstacles to the implementation of directly observed treatment in Ouagadougou, Burkina Faso.
Ouédraogo M; Kouanda S; Dembélé M; Ouédraogo SM; Badoum G; Ouédraogo G; Bambara M; Yaogho MG; Drabo YJ
Int J Tuberc Lung Dis; 2006 Feb; 10(2):188-91. PubMed ID: 16499259
[TBL] [Abstract][Full Text] [Related]
2. Treatment seeking behaviour of smear-positive tuberculosis patients diagnosed in Burkina Faso.
Ouédraogo M; Kouanda S; Boncoungou K; Dembélé M; Zoubga ZA; Ouédraogo SM; Coulibaly G
Int J Tuberc Lung Dis; 2006 Feb; 10(2):184-7. PubMed ID: 16499258
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with compliance among tuberculosis patients in Thailand.
Lertmaharit S; Kamol-Ratankul P; Sawert H; Jittimanee S; Wangmanee S
J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S149-56. PubMed ID: 16623020
[TBL] [Abstract][Full Text] [Related]
4. DOT or not? Direct observation of anti-tuberculosis treatment and patient outcomes, Kerala State, India.
Balasubramanian VN; Oommen K; Samuel R
Int J Tuberc Lung Dis; 2000 May; 4(5):409-13. PubMed ID: 10815733
[TBL] [Abstract][Full Text] [Related]
5. Conversion rate at two-month follow-up of smear-positive tuberculosis patients in Burkina Faso.
Dembele SM; Ouedraogo HZ; Combary A; Saleri N; Macq J; Dujardin B
Int J Tuberc Lung Dis; 2007 Dec; 11(12):1339-44. PubMed ID: 18034956
[TBL] [Abstract][Full Text] [Related]
6. Factors contributing to poor compliance with anti-TB treatment among tuberculosis patients.
Naing NN; D'Este C; Isa AR; Salleh R; Bakar N; Mahmod MR
Southeast Asian J Trop Med Public Health; 2001 Jun; 32(2):369-82. PubMed ID: 11556591
[TBL] [Abstract][Full Text] [Related]
7. Directly observed therapy (DOT) is not the entire answer: an operational cohort analysis.
Mangura B; Napolitano E; Passannante M; Sarrel M; McDonald R; Galanowsky K; Reichman L
Int J Tuberc Lung Dis; 2002 Aug; 6(8):654-61. PubMed ID: 12150475
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for multidrug-resistant tuberculosis in four centers in Burkina Faso, West Africa.
Diandé S; Sangaré L; Kouanda S; Dingtoumda BI; Mourfou A; Ouédraogo F; Sawadogo I; Nébié B; Gueye A; Sawadogo LT; Traoré AS
Microb Drug Resist; 2009 Sep; 15(3):217-21. PubMed ID: 19728781
[TBL] [Abstract][Full Text] [Related]
9. DOT and timely treatment completion among Asian-born immigrant tuberculosis patients.
Liu SY; Li JH; Schluger NW
Int J Tuberc Lung Dis; 2005 Aug; 9(8):884-9. PubMed ID: 16104635
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting patient adherence to DOTS in urban Kathmandu, Nepal.
Bam TS; Gunneberg C; Chamroonsawasdi K; Bam DS; Aalberg O; Kasland O; Shiyalap K; Srisorrachatr S
Int J Tuberc Lung Dis; 2006 Mar; 10(3):270-6. PubMed ID: 16562706
[TBL] [Abstract][Full Text] [Related]
11. Community DOT for tuberculosis in a Brazilian favela: comparison with a clinic model.
Cavalcante SC; Soares EC; Pacheco AG; Chaisson RE; Durovni B;
Int J Tuberc Lung Dis; 2007 May; 11(5):544-9. PubMed ID: 17439679
[TBL] [Abstract][Full Text] [Related]
12. Treatment of tuberculosis in a rural area of Haiti: directly observed and non-observed regimens. The experience of H pital Albert Schweitzer.
Ollé-Goig JE; Alvarez J
Int J Tuberc Lung Dis; 2001 Feb; 5(2):137-41. PubMed ID: 11258507
[TBL] [Abstract][Full Text] [Related]
13. Medication-adherence predictors among patients with tuberculosis or human immunodeficiency virus infection in Burkina Faso.
Méda ZC; Lin YT; Sombié I; Maré D; Morisky DE; Chen YM
J Microbiol Immunol Infect; 2014 Jun; 47(3):222-32. PubMed ID: 23769812
[TBL] [Abstract][Full Text] [Related]
14. Directly observed treatment is associated with reduced default among foreign tuberculosis patients in Thailand.
Kapella BK; Anuwatnonthakate A; Komsakorn S; Moolphate S; Charusuntonsri P; Limsomboon P; Wattanaamornkiat W; Nateniyom S; Varma JK
Int J Tuberc Lung Dis; 2009 Feb; 13(2):232-7. PubMed ID: 19146753
[TBL] [Abstract][Full Text] [Related]
15. Factors affecting patient compliance with anti-tuberculosis chemotherapy using the directly observed treatment, short-course strategy (DOTS).
O'Boyle SJ; Power JJ; Ibrahim MY; Watson JP
Int J Tuberc Lung Dis; 2002 Apr; 6(4):307-12. PubMed ID: 11936739
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of DOT for tuberculosis treatment outcomes: a prospective cohort study in Bangkok, Thailand.
Okanurak K; Kitayaporn D; Wanarangsikul W; Koompong C
Int J Tuberc Lung Dis; 2007 Jul; 11(7):762-8. PubMed ID: 17609051
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for non-adherence to directly observed treatment (DOT) in a rural tuberculosis unit, South India.
Gopi PG; Vasantha M; Muniyandi M; Chandrasekaran V; Balasubramanian R; Narayanan PR
Indian J Tuberc; 2007 Apr; 54(2):66-70. PubMed ID: 17575677
[TBL] [Abstract][Full Text] [Related]
18. Tuberculosis treatment delivery in high burden settings: does patient choice of supervision matter?
Kironde S; Meintjies M
Int J Tuberc Lung Dis; 2002 Jul; 6(7):599-608. PubMed ID: 12102299
[TBL] [Abstract][Full Text] [Related]
19. Persistence of gaps in implementation of revised national tuberculosis control program in an area of West Bengal.
Sen TK; Das DK; Saha S
Indian J Public Health; 2007; 51(4):246-8. PubMed ID: 18232169
[TBL] [Abstract][Full Text] [Related]
20. Auditing the new decentralised oral treatment regimens in Malawi.
Nyirenda TE; Harries AD; Gausi FK; Ito K; Kemp JR; Squire BS; Godfrey-Faussett P; Salaniponi FM
Int J Tuberc Lung Dis; 2004 Sep; 8(9):1089-94. PubMed ID: 15455593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
